Zulfiquer Otty

Adept at diagnosing and developing treatment plans for patients with solid tumours, while helping junior medical professionals learn to do the same. Familiar with completing rounds, reviewing records and educating patients and families. Skilled Doctor with extensive experience in patient care, diagnosis and providing quality medical services. Adept at managing medical teams and resolving complex medical cases with utmost precision. Possesses outstanding organizational and communication skills.

Particular interest in managing patients with lung cancer, head & neck cancer and melanomas.

Chairperson of Townsville Hospital lung cancer multi-disciplinary team.

Actively involved in research to improve outcomes of rural, remote and indigenous patients. Research focussed on integrated health, looking at developing a common governance linking primary health care and tertiary specialist services to streamline cancer pathways.

member of Australian Lung cancer Screening Trials group.

• Otty Z, Larkins S, Evans R, Brown A, Sabesan S. Clinicians’ Experiences and Perspectives about a New Lung Cancer Referral Pathway in a Regional Health Service. International Journal of Integrated Care, 2024; 24(2): 3, 1–11. DOI: https://doi.org/10.5334/ijic.7627
• Otty Z, et al. Optimal Care Pathways for People with Lung Cancer- a Scoping Review of the Literature. International Journal of Integrated Care, 2020; 20(3): 14, 1–9. DOI: https://doi.org/10.5334/ijic.5438
• Z Otty, A Brown, S Larkins, R Evans, S Sabesan. Patients’ and their carers’ experiences of lung cancer referral pathway within a regional health service: A qualitative study .Internal Medicine Journal. 2023 jan 29.doi:10.1111/imj.16022
• Otty Z et al. Improving timeliness of care for regional lung cancer patients through implementation of a web-based lung cancer referral pathway- under peer review
• Otty Z, Skinner MB, Dass J, Collins M, Mooi J, Thuraisingam K, Sabesan S. Efficacy and tolerability of weekly low-dose cisplatin concurrent with radiotherapy in head and neck cancer patients. Asia Pac J Clin Oncol. 2011 Sep;7(3):287-92. doi: 10.1111/j.1743-7563.2011.01405.x. PMID: 21884441.
• Sabesan S, Senko C, Schmidt A, Joshi A, Pandey R, Ryan CA, Lyle M, Rainey N, Varma S, Otty Z, Ansari Z, Vaughan K, Vangaveti V, Black J, Brown A. Enhancing Chemotherapy Capabilities in Rural Hospitals: Implementation of a Telechemotherapy Model (QReCS) in North Queensland, Australia. J Oncol Pract. 2018 Jul;14(7):e429-e437. doi: 10.1200/JOP.18.00110. PMID: 29996068.
• Verma, R., Pathmanathan, S., Otty, Z.A., Binder, J., Vangaveti, V.N., Buttner, P. and Sabesan, S.S. (2018), Delays in lung cancer management pathways between rural and urban patients in North Queensland: a mixed methods study. Intern Med J, 48: 1228-1233. https://doi.org/10.1111/imj.13934
• Tan JY, Otty ZA, Vangaveti VN, Buttner P, Varma SC, Joshi AJ, Kelly J, Collins M, Sabesan SS. A prospective comparison of times to presentation and treatment of regional and remote head and neck patients in North Queensland, Australia. Intern Med J. 2016 Aug;46(8):917-24. doi: 10.1111/imj.13138. PMID: 27246246.
• Field, K., Shapiro, J., Yip, D., Otty, Z., Burge, M., Sharma, A., ... Gibbs, P. (2012). PATTERNS OF CARE ACCORDING TO TREATMENT INTENT FOR METASTATIC COLORECTAL CANCER: A REVIEW OF ROUTINE PRACTICE. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8 pp. 51-52.
• Sabesan S, Burgher B, Buettner P, Piliouras P, Otty Z, Varma S, Thaker D. Attitudes, knowledge and barriers to participation in cancer clinical trials among rural and remote patients. Asia Pac J Clin Oncol. 2011 Mar;7(1):27-33. doi: 10.1111/j.1743-7563.2010.01342.x. Epub 2010 Nov 3. PMID: 21332648.
• Bajaj P, Otty Z, sabesan S. p PALLIATIVE CAR REFERRALS AND TIME PERIOD BETWEEN LAST CHEMOTHERAPY AND DEATH IN METASTATIC BREAST CANCER PATIENTS IN NORTH QUEENSLAND. November 2013.Asia-Pacific Journal of Clinical Oncology.
• Otty Z, sabesan S. Non-hodgkin’s lymphoma while on treatment with temozolomide-. Asia-pacific journalof clinical oncology,2012.
• Rodrigues B, Otty Z, etal. ipilimumab induced auto immune hypophysitis: a differential for stellar mass lesions. December 2014

Endocrinology Diabetes and Metabolism Case Reports 2014:140098. DOI:10.1530/EDM-14-0098.

·

• Otty Z et al. Improving timeliness of diagnosis of lung cancer patients through implementation of a web-based lung cancer referral pathway. March 2024, ESMO Open 9:102757, DOI:10.1016/j.esmoop.2024.10275
• Otty Z et al. A prospective comparison of times to presentation and treatment of rural and urban head and neck cancer patients in north Queensland. Conference: ASCO annual meeting 2014
• Joshi A, Sabesan S, Otty Z. Feasibility and safety of chemotherapy administration using Tele-Oncology for rural lung cancer patients in North Queensland. October 2013, Conference: 15th World Conference on Lung Cancer, Sydney
• Joshi A, Sabesan S, Beuttner P, Varma S, Otty Z. Times to presentation and treatment: a prospective comparison of rural and urban lung cancer patients in North Queensland. In: Journal of Thoracic Oncology. 15th World Conference on Lung Cancer. 2013 Oct 28; Sydney, Australia.
• Otty Z et al. RESPONSE RATES OF HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMAS (OPSCC), TREATED WITH LOW-DOSE, WEEKLY CISPLATIN CONCURRENT WITH RADIATION. July 2013, Asia-Pacific Journal of Clinical Oncology.
• Otty Z et al. PATTERNS OF CARE FOR LIMITED-STAGE SMALL-CELL LUNG CANCER IN A REGIONAL/RURAL SETTING - A NORTH QUEENSLAND EXPERIENCE, March 2011, Journal of Thoracic Oncology 6(3):S27-S27.
• Otty Z et al. Efficacy of weekly cisplatin 40mg/m 2 in definitive and adjuvant chemoradiation of head and neck cancer: A retrospective analysis.

May 2011. Journal of Clinical Oncology 29(15_suppl):e16039-e16039. DOI: 10.1200/jco.2011.29.15_suppl.e16039.

SERTA fellowship grant from Townsville University Hospital research committee-2023-24. amount- AUD $ 100,000.00

SERTA grant for employing research assistant 2012. 

ALST

IASLC

ASCO

ESMO

MOGA

COSA

TOGA

RACP

ANHNCS

AGITG